ANNUAL REPORT AND ACCOUNTS
NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.
The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.
The Company's Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
|
-Ends-
|
For further information please contact:
|
ImmuPharma plc (www.immupharma.org)
|
+ 44 (0) 20 7152 4080
|
|
Tim McCarthy, Chairman
|
|
|
Lisa Baderoon, Head of Investor Relations
Twitter: @immupharma
|
+ 44 (0) 7721 413496
|
|
Panmure, Gordon (UK) Limited, NOMAD & Broker
|
+44 (0) 20 7886 2500
|
|
Fred Walsh / Duncan Monteith, Corporate Finance
Charles Leigh-Pemberton, Corporate Broking
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|